Last reviewed · How we verify
NCT03301519
Genetics of Beta Cell Failure in Mexican Americans
trial in Gestational Diabetes in 1,250 participants. Completed in 31 May 2013.
31 May 2013
Quick facts
| Lead sponsor | University of Southern California |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,250 |
| Start date | 1 July 2001 |
| Primary completion | 31 May 2013 |
| Estimated completion | 31 May 2013 |
Conditions studied
- Gestational Diabetes — all drugs for Gestational Diabetes →
- Diabetes Type 2 — all drugs for Diabetes Type 2 →
- Insulin Resistance — all drugs for Insulin Resistance →
- Beta Cell Function — all drugs for Beta Cell Function →
Sponsor
University of Southern California
Who can join
8 and older, any sex, with Gestational Diabetes or Diabetes Type 2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a family based genotype-phenotype study designed to assess genetic and environmental influences on obesity, insulin resistance and beta cell function in the context of gestational diabetes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A diet high in sugar-sweetened beverage and low in fruits and vegetables is associated with adiposity and a pro-inflammatory adipokine profile.
Koebnick C, Black MH, Wu J, Shu YH, et al · · 2018 · cited 41× · PMID 30375290 · DOI 10.1017/s0007114518002726
Verify or expand the search:
- PubMed search for NCT03301519
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gestational Diabetes
Currently open trials in the same condition.
- NCT07171684 — Single vs Multi-Dose Insulin for Glycemic Control (SUGAR) · NA · recruiting
- NCT07314944 — Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes · recruiting
- NCT06571487 — Growth Hormone Resistance of Beta-cells · recruiting
- NCT07336914 — Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes · NA · recruiting
- NCT07174245 — Pregnancy and Postpartum CGM in GDM · recruiting
Other University of Southern California trials
Trials by the same sponsor.
- NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
- NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
- NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
- NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
- NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03301519 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern California
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03301519.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing